Healthcare Transactions and Regulatory
- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Healthcare Transactions and Regulatory
Healthcare Transactions and Regulatory
The combination of our senior transactional counsel and our regulatory expertise makes us valued counsel in closing healthcare industry mergers, acquisitions, joint ventures, affiliations and other collaborations. Our practice is national in scope and involves all substantive aspects of healthcare transactions, including multistate regulatory approvals, legal risk assessments, tax structuring, antitrust analysis, and public company and going-private issues.
Lawyers
View all
Insights
Client Alert
April 2, 2021
Florida Passes Law Limiting COVID-19 Lawsuits
Newsletter
July 30, 2018
Health Headlines – July 30, 2018
Newsletter
July 16, 2018
Health Headlines – July 16, 2018
News
Recognition
May 25, 2018
King & Spalding Wins Chambers USA’s 2018 Healthcare Award
In the News · Source: Bloomberg Big Law Business
July 16, 2018
Mark Polston discusses how a recent Supreme Court ruling will impact the Health and Human Services Medicare appeals backlog
In the News · Source: Bloomberg Law, Bloomberg Tax, Law360, ICLG News, The American Lawyer, New York Law Journal, The Deal, The National Law Journal and Thomson Reuters Westlaw Today
January 26, 2021
Healthcare partner Rick Zall joins the firm’s healthcare transactional and regulatory practice group in New York
Cases & Deals
July 3, 2020
Athyrium Capital Management Completes Out-of-Court Restructuring of Senior Secured Notes Issued by VIVUS, Inc.
Close